Opdivo® (Nivolumab) Intravenous Infusion Approved for Supplemental Indication of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck with Disease Progression on or after Platinum-based Therapy in Taiwan 2017.08.16
Month: August 2017
QIA Direct Equity Ownership in Credit Suisse Falls Below 5%
Cerberus Sells Out Seibu Shareholdings 20170816
HondaJet Obtains Brazilian Type Certification. Aug 15, 2017 – GREENSBORO, N.C.
Snack, Crackle, Drop! Temasek Exits Snapcha